BioCardia Inc. (NASDAQ: BCDA) is -42.56% lower on its value in year-to-date trading and has touched a low of $0.36 and a high of $2.92 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BCDA stock was last observed hovering at around $0.42 in the last trading session, with the day’s loss setting it -0.04%.
Currently trading at $0.38, the stock is -16.65% and -24.52% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.57 million and changing -9.49% at the moment leaves the stock -58.95% off its SMA200. BCDA registered -81.39% loss for a year compared to 6-month loss of -12.50%. The firm has a 50-day simple moving average (SMA 50) of $16.58 and a 200-day simple moving average (SMA200) of -$0.76.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -6.95% gain in the last 1 month and extending the period to 3 months gives it a -39.35%, and is -6.97% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.15% over the week and 10.92% over the month.
BioCardia Inc. (BCDA) has around 36 employees, a market worth around $9.88M and $0.57M in sales. Profit margin for the company is -2197.72%. Distance from 52-week low is 5.97% and -86.93% from its 52-week high. The company has generated returns on investments over the last 12 months (-3004.08%).
BioCardia Inc. quarterly earnings per share for the current quarter are estimated at -$0.11 with sales reaching $90k over the same period.The EPS is expected to grow by 45.52% this year, but quarterly earnings will post -57.10% year-over-year. Quarterly sales are estimated to shrink -15.10% in year-over-year returns.
BioCardia Inc. (BCDA) Top Institutional Holders
26 institutions hold shares in BioCardia Inc. (BCDA), with institutional investors hold 12.60% of the company’s shares. The shares outstanding are 20.08M, and float is at 16.38M with Short Float at 0.60%. Institutions hold 8.04% of the Float.
The top institutional shareholder in the company is Vanguard Group Inc with over 0.65 million shares valued at $1.74 million. The investor’s holdings represent 13.42% of the BCDA Shares outstanding. As of Jun 29, 2023, the second largest holder is CM Management, LLC with 0.34 million shares valued at $0.92 million to account for 7.08% of the shares outstanding. The other top investors are Geode Capital Management, LLC which holds 0.15 million shares representing 2.99% and valued at over $0.39 million, while Lynwood Capital Management Inc. holds 2.66% of the shares totaling 0.13 million with a market value of $0.34 million.
BioCardia Inc. (BCDA) Insider Activity
The most recent transaction is an insider purchase by Altman Peter,the company’sPresident and CEO. SEC filings show that Altman Peter bought 108,108 shares of the company’s common stock on Feb 13 ’24 at a price of $0.46 per share for a total of $50000.0. Following the purchase, the insider now owns 0.56 million shares.
BioCardia Inc. disclosed in a document filed with the SEC on Jan 19 ’24 that FROST PHILLIP MD ET AL (10% Owner) sold a total of 129,802 shares of the company’s common stock. The trade occurred on Jan 19 ’24 and was made at $0.43 per share for $55815.0. Following the transaction, the insider now directly holds 1.9 million shares of the BCDA stock.
Still, SEC filings show that on May 26 ’23, Altman Peter (President and CEO) acquired 6,200 shares at an average price of $1.60 for $9920.0. The insider now directly holds 469,239 shares of BioCardia Inc. (BCDA).
